Want to see TSE:GPIN full AI Analyst Report?

Steep Hill Inc (GPIN) Price & Analysis

1 Followers

GPIN Stock Chart & Stats

C$0.06

C$0.00(0.00%)

At close: Jan 08 4:00 PM EST

C$0.06

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.12 - C$0.75

Previous CloseN/A

VolumeN/A

Average Volume (3M)12.40K

Market Cap

C$14.20M

Enterprise Value-C$33.13K

Total Cash (Recent Filing)C$2.03M

Total Debt (Recent Filing)C$0.00

Price to Earnings (P/E)0.4

Beta0.68

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding40,563,385

10 Day Avg. Volume9,973

30 Day Avg. Volume12,401

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)0.12

Price to Sales (P/S)0.00

P/FCF Ratio-0.64

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Industry PartnershipsPartnerships with industry players and regulatory bodies enhance Steep Hill's credibility and revenue potential, supporting long-term business sustainability and compliance.

Strong Balance SheetA strong balance sheet with no debt provides financial stability and flexibility, allowing Steep Hill to invest in growth opportunities without the burden of leverage.

Strategic AcquisitionThe acquisition of Lir Life Sciences positions Steep Hill in the biopharmaceutical sector, potentially expanding its market reach and product offerings, which could enhance long-term growth prospects.

Bears Say

Operational InefficienciesPersistent operational inefficiencies, as indicated by negative margins, suggest challenges in cost management and profitability, affecting long-term business viability.

Negative Cash FlowNegative cash flow indicates operational inefficiencies and potential liquidity challenges, which could hinder Steep Hill's ability to sustain operations without external financing.

Lack Of RevenueThe absence of revenue poses a significant risk to Steep Hill's long-term sustainability, as it limits the company's ability to fund operations and growth initiatives.

GPIN FAQ

What was Steep Hill Inc’s price range in the past 12 months?

Steep Hill Inc lowest stock price was C$0.12 and its highest was C$0.75 in the past 12 months.

What is Steep Hill Inc’s market cap?

Steep Hill Inc’s market cap is C$14.20M.

When is Steep Hill Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Steep Hill Inc’s earnings last quarter?

Currently, no data Available

Is Steep Hill Inc overvalued?

According to Wall Street analysts Steep Hill Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Steep Hill Inc pay dividends?

Steep Hill Inc does not currently pay dividends.

What is Steep Hill Inc’s EPS estimate?

Steep Hill Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Steep Hill Inc have?

Steep Hill Inc has 40,563,385 shares outstanding.

What happened to Steep Hill Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Steep Hill Inc?

Currently, no hedge funds are holding shares in TSE:GPIN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Steep Hill Inc

Steep Hill Inc., a cannabis science and technology company, provides laboratory testing, quality assurance, and data analytics services in Canada and the United States. It offers analytical testing services, such as cannabinoids, terpenes, pesticides analysis, mycotoxins analysis, heavy metals analysis, residual solvents analysis, microbial analysis, foreign matter inspection, moisture content analysis, water activity analysis, vitamin E acetate, homogeneity testing, and hemp analysis, as well as consulting services in the areas of analytical testing, cannabis testing regulations, test methods, laboratory information management systems, and product quality and safety. The company was formerly known as Cannabis Clonal Corporation and changed its name to Steep Hill Inc. in February 2022. Steep Hill Inc. was founded in 2008 and is based in Toronto, Canada.